An Update to the Article “Efficacy and Side Effect Profile of Different Formulations of Metformin: A Systematic Review and Meta-Analysis” Catherine AikenJane Tarry-AdkinsSusan Ozanne Editorial Open access 01 October 2021 Pages: 2813 - 2816
The Value of Insulin Degludec in Frail Older Adults with Type 2 Diabetes W. David StrainAngharad R. MorganMarc Evans Commentary Open access 04 October 2021 Pages: 2817 - 2826
A Review of Interventional Trials in Youth-Onset Type 2 Diabetes: Challenges and Opportunities Brooke M. CurrieTimothy A. HowellJoseph A. Johnston Review Open access 23 September 2021 Pages: 2827 - 2856
Lower COVID-19 Mortality in Patients with Type 2 Diabetes Mellitus Taking Dipeptidyl Peptidase-4 Inhibitors: Results from a Turkish Nationwide Study Rifat EmralCem HaymanaAlper Sonmez Original Research Open access 16 August 2021 Pages: 2857 - 2870
Correction to: Lower COVID-19 Mortality in Patients with Type 2 Diabetes Mellitus Taking Dipeptidyl Peptidase-4 Inhibitors: Results from a Turkish Nationwide Study Rifat EmralCem HaymanaAlper Sonmez Correction Open access 24 September 2021 Pages: 2871 - 2872
Immediate Glucose-Lowering Effect After the First Administration of Dulaglutide: A Retrospective, Single-Center, Observational Study Sakiko TeruiRyoichi AkamatsuJun Shirakawa Original Research Open access 17 September 2021 Pages: 2873 - 2889
Real-World Use of Once-Weekly Semaglutide in Type 2 Diabetes: Results from the SURE UK Multicentre, Prospective, Observational Study Patrick HolmesHeather Elizabeth BellThozhukat Sathyapalan Original Research Open access 25 September 2021 Pages: 2891 - 2905
Efficacy and Safety of Switching to Teneligliptin in Patients with Type 2 Diabetes Inadequately Controlled with Dipeptidyl Peptidase-4 Inhibitors: 52-Week Results from a Prospective Observational Study Hae Jin KimYoung Sik KimKwan Woo Lee Original Research Open access 18 September 2021 Pages: 2907 - 2920
Nationwide Prevalence of Diabetes and Prediabetes and Associated Risk Factors Among Iranian Adults: Analysis of Data from PERSIAN Cohort Study Mohammad E. KhamsehSadaf G. SepanlouReza Malekzadeh Original Research Open access 30 September 2021 Pages: 2921 - 2938
Satisfaction, Preference and Injection Habits of Switching to 200 Units/ml Insulin Lispro Pen from 100 Units/ml: A Patient Survey in Germany Jieling ChenPaul WilliamsMatthias Blüher Original Research Open access 20 September 2021 Pages: 2939 - 2953
Association of Acarbose with Decreased Muscle Mass and Function in Patients with Type 2 Diabetes: A Retrospective, Cross-Sectional Study Lan-lan JiangXiao-hua XuJian-hua Ma Original Research Open access 20 September 2021 Pages: 2955 - 2969
The Role of Pediatric BCG Vaccine in Type 1 Diabetes Onset John DoupisKonstantinos KolokathisTheodoros Angelopoulos Original Research Open access 01 October 2021 Pages: 2971 - 2976
The Cost-Effectiveness of an Advanced Hybrid Closed-Loop System in People with Type 1 Diabetes: a Health Economic Analysis in Sweden Johan JendleM. I. BuompensiereO. Cohen Original Research Open access 01 October 2021 Pages: 2977 - 2991
Effectiveness and Safety of Insulin Glargine 300 U/ml in Comparison with Insulin Degludec 100 U/ml Evaluated with Continuous Glucose Monitoring in Adults with Type 1 Diabetes and Suboptimal Glycemic Control in Routine Clinical Practice: The OneCARE Study Ignacio CongetMiguel Ángel MangasElías Delgado Original Research Open access 02 October 2021 Pages: 2993 - 3009
Impact of SARS-CoV-2 on Progression of Glycemic and Cardiometabolic Variables and Changes in Insulin Indices: A Longitudinal Study Alpesh GoyalYashdeep GuptaNikhil Tandon Original Research Open access 05 October 2021 Pages: 3011 - 3023